ITRM20010218A0 - Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi - Google Patents

Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi

Info

Publication number
ITRM20010218A0
ITRM20010218A0 IT2001RM000218A ITRM20010218A ITRM20010218A0 IT RM20010218 A0 ITRM20010218 A0 IT RM20010218A0 IT 2001RM000218 A IT2001RM000218 A IT 2001RM000218A IT RM20010218 A ITRM20010218 A IT RM20010218A IT RM20010218 A0 ITRM20010218 A0 IT RM20010218A0
Authority
IT
Italy
Prior art keywords
children
prevention
treatment
composition
attention deficit
Prior art date
Application number
IT2001RM000218A
Other languages
English (en)
Inventor
Franco Gaetani
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Priority to IT2001RM000218A priority Critical patent/ITRM20010218A1/it
Publication of ITRM20010218A0 publication Critical patent/ITRM20010218A0/it
Priority to HU0303963A priority patent/HUP0303963A3/hu
Priority to PL01367613A priority patent/PL367613A1/xx
Priority to PCT/IT2001/000430 priority patent/WO2002085341A2/en
Priority to US10/250,359 priority patent/US20040058947A1/en
Priority to ES01961133T priority patent/ES2237591T3/es
Priority to DE60109651T priority patent/DE60109651T2/de
Priority to CA002436240A priority patent/CA2436240A1/en
Priority to DK01961133T priority patent/DK1383579T3/da
Priority to PT01961133T priority patent/PT1383579E/pt
Priority to MXPA03009631A priority patent/MXPA03009631A/es
Priority to AT01961133T priority patent/ATE291468T1/de
Priority to EP01961133A priority patent/EP1383579B1/en
Publication of ITRM20010218A1 publication Critical patent/ITRM20010218A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
IT2001RM000218A 2001-04-23 2001-04-23 Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi ITRM20010218A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT2001RM000218A ITRM20010218A1 (it) 2001-04-23 2001-04-23 Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi
EP01961133A EP1383579B1 (en) 2001-04-23 2001-08-03 Composition, containing carnitine and huperzin for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
DE60109651T DE60109651T2 (de) 2001-04-23 2001-08-03 Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern
PL01367613A PL367613A1 (en) 2001-04-23 2001-08-03 Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
PCT/IT2001/000430 WO2002085341A2 (en) 2001-04-23 2001-08-03 Composition, containing carnitine and huperzin for the preventionor treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
US10/250,359 US20040058947A1 (en) 2001-04-23 2001-08-03 Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
ES01961133T ES2237591T3 (es) 2001-04-23 2001-08-03 Composicion que contiene carnitina y huperzina para la prevencion o tratamiento de trastornos del aprendizaje en niños que sufren de trastornos de deficit de atencion/hiperactividad.
HU0303963A HUP0303963A3 (en) 2001-04-23 2001-08-03 Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
CA002436240A CA2436240A1 (en) 2001-04-23 2001-08-03 Composition, containing carnitine and huperzin for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
DK01961133T DK1383579T3 (da) 2001-04-23 2001-08-03 Præparat, der indeholder carnitin og huperzin til forebyggelse eller behandling af indlæringsvanskeligheder hos börn, der lider af opmærksomhedsforstyrrelse/hyperaktiv lidelse (ADHD)
PT01961133T PT1383579E (pt) 2001-04-23 2001-08-03 Composicao contendo carnitina e huperzina para a prevencao ou o tratamento de disturbios de aprendizagem em criancas que sofrem do disturbio de defice de atencao com hiperactividade
MXPA03009631A MXPA03009631A (es) 2001-04-23 2001-08-03 Composicion para prevencion o tratamiento de trastornos del aprendizaje en ninos que sufren del trastorno de deficit de atencion/hiperactivo.
AT01961133T ATE291468T1 (de) 2001-04-23 2001-08-03 Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000218A ITRM20010218A1 (it) 2001-04-23 2001-04-23 Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi

Publications (2)

Publication Number Publication Date
ITRM20010218A0 true ITRM20010218A0 (it) 2001-04-23
ITRM20010218A1 ITRM20010218A1 (it) 2002-10-23

Family

ID=11455486

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001RM000218A ITRM20010218A1 (it) 2001-04-23 2001-04-23 Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi

Country Status (12)

Country Link
US (1) US20040058947A1 (it)
EP (1) EP1383579B1 (it)
AT (1) ATE291468T1 (it)
CA (1) CA2436240A1 (it)
DE (1) DE60109651T2 (it)
ES (1) ES2237591T3 (it)
HU (1) HUP0303963A3 (it)
IT (1) ITRM20010218A1 (it)
MX (1) MXPA03009631A (it)
PL (1) PL367613A1 (it)
PT (1) PT1383579E (it)
WO (1) WO2002085341A2 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2390055B (en) 2002-03-22 2005-09-07 Cypher Science Internat Ltd A marking apparatus
CN100441200C (zh) * 2004-11-26 2008-12-10 谢德隆 石杉碱甲、乙复合成分的蛇足石杉提取物及其制备方法
GB201205856D0 (en) * 2012-04-02 2012-05-16 Randall Jeremy A P Food supplement to support brain function
CN102702101B (zh) * 2012-05-23 2016-04-06 长沙市惠瑞生物科技有限公司 一种从千层塔中提取石杉碱甲的方法
CN103667072B (zh) * 2013-09-27 2016-04-13 浙江工业大学 一种蛇足石杉内生真菌及其在制备8α,15α-环氧化石杉碱甲的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL132634A0 (en) * 1997-04-29 2001-03-19 Kenneth Blum Inc Allelic polygene diagnosis of reward deficiency syndrome and treatment
US5869528A (en) * 1997-07-22 1999-02-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutical method for the treatment of attention-deficit/hyperactive disorders
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function

Also Published As

Publication number Publication date
US20040058947A1 (en) 2004-03-25
DE60109651D1 (de) 2005-04-28
ITRM20010218A1 (it) 2002-10-23
HUP0303963A2 (hu) 2004-04-28
PL367613A1 (en) 2005-03-07
PT1383579E (pt) 2005-06-30
DE60109651T2 (de) 2006-04-27
EP1383579A2 (en) 2004-01-28
ATE291468T1 (de) 2005-04-15
WO2002085341A2 (en) 2002-10-31
CA2436240A1 (en) 2002-10-31
ES2237591T3 (es) 2005-08-01
HUP0303963A3 (en) 2005-04-28
EP1383579B1 (en) 2005-03-23
MXPA03009631A (es) 2004-06-30
WO2002085341A3 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
ATE286028T1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DK0966436T3 (da) Arylsulfonamider og analoger deraf og anvendelse deraf til behandling af neurodegenerative lidelser
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DE60026627D1 (de) Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
IS8135A (is) Þríhringtengdar indólafleiður og notkun þeirra til að meðhöndla Alzheimers-sjúkdóm
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
DK1117394T3 (da) Anvendelse af carnitiner og resveratrol til fremstilling af et præparat til forebyggelse eller terapeutisk behandling af cerabrale lidelser forårsaget af aldring og anvendelse af neurotoksiske medikamenter
EE200200442A (et) Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
IS7203A (is) 4[píperidín-4-ýliden-(3-karbamólýlfenýl)metýl]bensamíðafleiður og notkun þeirra til að meðhöndla verki, mænuskaða eða maga- og garnasjúkdóma
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
DE60002226D1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
ATE323685T1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
ITRM20010218A0 (it) Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi
AU2001242130A1 (en) Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
DE60012789D1 (de) Eine antivirale lotion-zusammensetzung und mit lotion behandeltes tissueprodukt
IT1306179B1 (it) Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
DE60233030D1 (de) Tartrat- und phosphatsalz von 3,4-diaminopyridin, pharmazeutische zusammensetzung und deren verwendung
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
ATE335473T1 (de) Zusammensetzung zur verhinderung und/oder behandlung von gefässerkrankungen, bestehend aus propionyl-l-carnitin und coenzym q10
HUP0202416A3 (en) Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders
FI972637A (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon